A 12-week, multi-centre, randomized, double-blind, placebo-controlled study to treat apathy in Alzheimer’s dementia with Bupropion (Apa-AD)

Title of project or programme
A 12-week, multi-centre, randomized, double-blind, placebo-controlled study to treat apathy in Alzheimer’s dementia with Bupropion (Apa-AD)
Principal Investigators of project/programme grant

Title	Forname	Surname	Institution	Country
Prof.	Frank	Jessen		Germany

Address of institution of lead PI

Institution
Street Address	Sigmund-Freud-Str. 25
City	Bonn
Postcode	53127

Country

• Germany

Source of funding information
Federal Ministry of Education and Research (BMBF)
Total sum awarded (Euro)
1227231
Start date of award
01-06-2009
Total duration of award in months
30
The project/programme is most relevant to

• Alzheimer’s disease and other dementias

Keywords

Research abstract in English

Lay summary

A 12-week, multi-centre, randomized, double-blind, placebo-controlled study to treat apathy in Alzheimer’s dementia with Bupropion (Apa-AD)

Investments > €500k
Germany
Alzheimer’s disease & other dementias
2011